Pancreatic cancer

van der Hage, 2021, The ESSO core curriculum committee update on surgical oncology, Eur J Surg Oncol, 47, e1, 10.1016/j.ejso.2021.10.003

Park, 2021, Pancreatic cancer: a review, JAMA, 326, 851, 10.1001/jama.2021.13027

Shah, 2022, Association between family history and risk of pancreatic cancer in patients with BRCA1 and BRCA2 pathogenic variants, Pancreas, 51, 733, 10.1097/MPA.0000000000002104

Sawhney, 2022, ASGE guideline on screening for pancreatic cancer in individuals with genetic susceptibility: summary and recommendations, Gastrointest Endosc, 95, 817, 10.1016/j.gie.2021.12.001

Laks, 2022, Management recommendations for pancreatic manifestations of von Hippel-Lindau disease, Cancer, 128, 435, 10.1002/cncr.33978

Søreide, 2022, Clinical management of pancreatic premalignant lesions, Gastroenterology, 162, 379, 10.1053/j.gastro.2021.09.073

Li, 2022, Cancer risks associated with BRCA1 and BRCA2 pathogenic variants, J Clin Oncol, Jco2102112

Leidner, 2022, Neoantigen T-cell receptor gene therapy in pancreatic cancer, N Engl J Med, 386, 2112, 10.1056/NEJMoa2119662

Sohal, 2020, Metastatic pancreatic cancer: ASCO guideline update, J Clin Oncol, 10.1200/JCO.20.01364

Tempero, 2021, Pancreatic adenocarcinoma, version 2.2021, NCCN clinical practice guidelines in oncology, J Natl Compr Cancer Netw, 19, 439, 10.6004/jnccn.2021.0017

Aziz, 2022, Comparison of society guidelines for the management and surveillance of pancreatic cysts: a review, JAMA Surg, 157, 723, 10.1001/jamasurg.2022.2232

Roalsø, 2020, Refined TNM-staging for pancreatic adenocarcinoma - real progress or much ado about nothing?, Eur J Surg Oncol, 46, 1554, 10.1016/j.ejso.2020.02.014

Khachfe, 2021, Borderline resectable and locally advanced pancreatic cancers: a review of definitions, diagnostics, strategies for treatment, and future directions, Pancreas, 50, 1243, 10.1097/MPA.0000000000001924

Christians, 2021, Pancreaticoduodenectomy and vascular reconstruction: indications and techniques, Surg Oncol Clin, 30, 731, 10.1016/j.soc.2021.06.011

Bratlie, 2021, Resectable, borderline, and locally advanced pancreatic cancer-"the good, the bad, and the ugly" candidates for surgery?, J Gastrointest Oncol, 12, 2450, 10.21037/jgo-2020-slapc-04

Kleive, 2021, Pancreatoduodenectomy with portal vein resection, 847

Søreide, 2021, Neoadjuvant and adjuvant therapy in operable pancreatic cancer: both honey and milk (but No bread?), Oncol Ther, 9, 1, 10.1007/s40487-020-00136-y

Oba, 2022, New criteria of resectability for pancreatic cancer: a position paper by the Japanese Society of Hepato-Biliary-Pancreatic Surgery (JSHBPS), J Hepatobiliary Pancreat Sci, 29, 725, 10.1002/jhbp.1049

Khorana, 2017, Potentially curable pancreatic cancer: American society of clinical oncology clinical practice guideline update, J Clin Oncol, 35, 2324, 10.1200/JCO.2017.72.4948

Seo, 2022, Preoperative therapy for pancreatic adenocarcinoma-precision beyond anatomy, Cancer, 128, 3041, 10.1002/cncr.34273

van Dam, 2022, Neoadjuvant therapy or upfront surgery for resectable and borderline resectable pancreatic cancer: a meta-analysis of randomised controlled trials, Eur J Cancer, 160, 140, 10.1016/j.ejca.2021.10.023

Katz, 2022, Efficacy of preoperative mFOLFIRINOX vs mFOLFIRINOX plus hypofractionated radiotherapy for borderline resectable adenocarcinoma of the pancreas: the A021501 phase 2 randomized clinical trial, JAMA Oncol, 8, 1263, 10.1001/jamaoncol.2022.2319

Chawla, 2021, Contemporary trials evaluating neoadjuvant therapy for resectable pancreatic cancer, J Surg Oncol, 123, 1423, 10.1002/jso.26393

Sternby, 2022, Nationwide trends and outcomes of neoadjuvant chemotherapy in pancreatic cancer - an analysis of the Swedish national pancreatic cancer registry, Scand J Gastroenterol, 57, 1361, 10.1080/00365521.2022.2078668

Labori, 2022, Short-course or total neoadjuvant chemotherapy in resectable and borderline resectable pancreatic cancer - current status and future perspectives, Front Surg, 9, 10.3389/fsurg.2022.839339

Du, 2022, Stent selection in preoperative biliary drainage for patients with operable pancreatic cancer receiving neoadjuvant therapy: a meta-analysis and systematic review, Front Surg, 9, 10.3389/fsurg.2022.875504

Lee, 2018, Preoperative biliary drainage in resectable pancreatic cancer: a systematic review and network meta-analysis, HPB, 20, 477, 10.1016/j.hpb.2017.12.007

Klaiber, 2019, Adjuvant treatment for pancreatic cancer, Transl Gastroenterol Hepatol, 4, 27, 10.21037/tgh.2019.04.04

Jones, 2019, Patterns of recurrence after resection of pancreatic ductal adenocarcinoma: a secondary analysis of the ESPAC-4 randomized adjuvant chemotherapy trial, JAMA Surg, 154, 1038, 10.1001/jamasurg.2019.3337

Conroy, 2022, Five-year outcomes of FOLFIRINOX vs gemcitabine as adjuvant therapy for pancreatic cancer: a randomized clinical trial, JAMA Oncol, 8, 1571, 10.1001/jamaoncol.2022.3829

Neoptolemos, 2017, Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial, Lancet, 389, 1011, 10.1016/S0140-6736(16)32409-6

Ahn, 2022, The continued struggle for defining a role for radiotherapy in pancreas cancer, JAMA Oncol, 8, 1257, 10.1001/jamaoncol.2022.2309

Kuemmerli, 2022, Impact of enhanced recovery protocols after pancreatoduodenectomy: meta-analysis, Br J Surg, 109, 256, 10.1093/bjs/znab436

Bongers, 2021, Enhanced recovery after surgery programmes in older patients undergoing hepatopancreatobiliary surgery: what benefits might prehabilitation have?, Eur J Surg Oncol, 47, 551, 10.1016/j.ejso.2020.03.211

Gianotti, 2018, Nutritional support and therapy in pancreatic surgery: a position paper of the International Study Group on Pancreatic Surgery (ISGPS), Surgery, 164, 1035, 10.1016/j.surg.2018.05.040

Phillips, 2021, Consensus for the management of pancreatic exocrine insufficiency: UK practical guidelines, BMJ Open Gastroenterol, 8, 10.1136/bmjgast-2021-000643

Russell, 2022, Results from a UK-wide survey: the nutritional assessment and management of pancreatic resection patients is highly variable, Eur J Clin Nutr, 76, 1038, 10.1038/s41430-021-01063-5

Gupta, 2022, Effect of exercise on pancreatic cancer patients during treatment: a scoping review of the literature, Support Care Cancer, 30, 5669, 10.1007/s00520-022-06925-7

Grochola, 2021, Standard pancreatoduodenectomy for resectable pancreatic cancer, 829

Søreide, 2021, Laparoscopic distal pancreatectomy, 967

Bayram, 2021, Total pancreatectomy, 941

Schneider, 2021, Technical advances in surgery for pancreatic cancer, Br J Surg, 108, 777, 10.1093/bjs/znab133

Hackert, 2020, Fifty years of surgery for pancreatic cancer, Pancreas, 49, 1005, 10.1097/MPA.0000000000001634

Ban, 2022, International expert consensus on precision anatomy for minimally invasive distal pancreatectomy: PAM-HBP surgery project, J Hepatobiliary Pancreat Sci, 29, 161, 10.1002/jhbp.1071

Asbun, 2020, The Miami international evidence-based guidelines on minimally invasive pancreas resection, Ann Surg, 271, 1, 10.1097/SLA.0000000000003590

Miao, 2020, Management of the pancreatic transection plane after left (distal) pancreatectomy: expert consensus guidelines by the International Study Group of Pancreatic Surgery (ISGPS), Surgery, 168, 72, 10.1016/j.surg.2020.02.018

Shrikhande, 2017, Pancreatic anastomosis after pancreatoduodenectomy: a position statement by the international study group of pancreatic surgery (ISGPS), Surgery, 161, 1221, 10.1016/j.surg.2016.11.021

Sachs, 2021, Landmark series in pancreatic tumors: anastomotic techniques and route of reconstruction, Ann Surg Oncol, 28, 2227, 10.1245/s10434-021-09663-y

Smits, 2022, Algorithm-based care versus usual care for the early recognition and management of complications after pancreatic resection in The Netherlands: an open-label, nationwide, stepped-wedge cluster-randomised trial, Lancet, 399, 1867, 10.1016/S0140-6736(22)00182-9

Besselink, 2017, Definition and classification of chyle leak after pancreatic operation: a consensus statement by the International Study Group on Pancreatic Surgery, Surgery, 161, 365, 10.1016/j.surg.2016.06.058

Marchegiani, 2022, Postpancreatectomy acute pancreatitis (PPAP): definition and grading from the international study group for pancreatic surgery (ISGPS), Ann Surg, 275, 663, 10.1097/SLA.0000000000005226

Toms, 2021, Quality of life instruments and trajectories after pancreatic cancer resection: a systematic review, Pancreas, 50, 1137, 10.1097/MPA.0000000000001896

Ratnayake, 2021, Margin accentuation irreversible electroporation in stage III pancreatic cancer: a systematic review, Cancers, 13, 10.3390/cancers13133212

Granata, 2021, Local ablation of pancreatic tumors: state of the art and future perspectives, World J Gastroenterol, 27, 3413, 10.3748/wjg.v27.i23.3413

Probst, 2021, Evidence map of pancreatic surgery-A living systematic review with meta-analyses by the international study group of pancreatic surgery (ISGPS), Surgery, 170, 1517, 10.1016/j.surg.2021.04.023